← Feed📈 Board🎯 Predictions🚧 Bottlenecks📐 Calibration📊 AnalysisLEU Thesis2026-08-17 7:00 PM · Centrus Energy Corp. Class A

LEU — Centrus Energy Corp. Class A

$184.12+12.88 (+7.52%)
Open 183.43 · High 186.02 · Low 182.51 · Vol 456,880
Delayed quote · 2026-08-17 3:57 PM · change vs prev close · source: Stooq
Running conviction (P)
0.87prior 0.65

Investment Read as of 2026-08-17

The Read

SOLID investment. Federal funding announcements and regulatory streamlining confirm LEU's position as a critical national infrastructure chokepoint, supporting the high conviction (P=0.87).

Bull case

Bear case / what breaks it

What the latest signal says

No fresh signal specifically names LEU. However, the combination of the $17.5B federal loan package [Source 7/5] and the NRC's proposal to modernize licensing [Source 7/16] validates the entire domestic nuclear supply chain thesis, reinforcing the critical need for a sole HALEU source.

Posterior history

DatePΔCallDriver
2026-07-170.87-0.03REVIEW/-Strengthening — two weeks of real federal money and regulatory tailwind (the $17.5B nuclea
2026-07-160.90+0.05UP/MEDNRC (T1, NEW) proposes a wholesale modernization of reactor licensing, siting, and safety
2026-07-100.85-0.04REVIEW/-Strengthening on substance, but the P has run ahead of it — the same $17.5B DOE loan progr
2026-07-050.89+0.05UP/MEDUS announced $17.5B in loans for the nuclear power supply chain — concrete federal money b
2026-07-030.84+0.05UP/MEDNEW 8-K (T1, 2026-07-02) decoded as "entered a material agreement" — for the sole US HALEU
2026-07-030.79-0.02REVIEW/-Strengthening on substance — three real catalysts in two weeks (Oklo offtake, DOE's $17.5B
2026-07-030.81+0.05UP/MEDT1 8-K: sole US HALEU enricher "entered a material agreement" (7/2) — likely offtake or DO
2026-06-260.76-0.02REVIEW/-Strengthening on substance but slightly over-run on price — two real bull prints (Oklo off
2026-06-230.78+0.05UP/MEDDOE unveiled a $17.5B conditional-loan program to "jumpstart the nuclear supply chain" and
2026-06-190.73+0.05UP/MEDCentrus (=LEU) signed a multi-year deal to supply domestic HALEU to Oklo's Aurora SMRs — a
2026-06-190.68-0.03REVIEW/-Stable, leaning slightly weak — the Oklo offtake gave the demand side its first real comme
2026-06-180.71+0.05UP/MEDCentrus (ticker LEU) signed a multi-year HALEU offtake to fuel Oklo's Aurora SMRs — and LE

Thesis detail

Core thesis

The only US producer of HALEU — the enriched fuel next-gen and small modular

reactors require. With Russian SWU banned, domestic enrichment is a strategic

monopoly in front of a multi-decade demand wave. Binary, but the option is on an

irreplaceable chokepoint.

Pillars (with priors)

1. Sole US HALEU enricher (~900 kg/yr vs. 50+ MT/yr projected 2030 demand) · P = 0.75

2. Russian SWU ban (phased to 2028/2040) removes ~30–45% of global supply · P = 0.80

3. DOE funding underwrites domestic enrichment expansion · P = 0.55

4. SMR / advanced-reactor pipeline = the HALEU demand curve · P = 0.50

Expected news (the prior)

Surface the residual: a second domestic enricher at scale, a funding cut,
or SMR timelines slipping is the signal.

Thesis-breaking triggers (→ set P near 0)

Leading vs lagging indicators

Key metrics

Valuation anchor

Binary, ~1.5:1 skew (≈ −50/−70% vs. +60/+100%). Lottery-ticket sizing on a

monopoly, per the sizing rules.

Cross-arena sensors

B2 (nuclear fuel/SMR), B7 (Russia ban/sanctions, enrichment policy).

Posterior log